Followers | 3598 |
Posts | 78318 |
Boards Moderated | 1 |
Alias Born | 03/25/2007 |
Monday, November 05, 2012 10:59:14 AM
The coFounder of AMGEN buys 1,000,000 shares at .01.
On October 26, 2012, Amarantus BioSciences, Inc. issued a Convertible Promissory Note to Dr. Joseph Rubinfeld, co-founder of Amgen, in the principal amount of $10,000.00. The Note bears interest at the rate of six percent (6%) per annum until paid in full and is convertible into shares of Amarantus common stock at the price of $0.01 per share upon ten (10) days written notice to Amarantus. Dr. Joseph Rubinfeld has submitted a conversion notice to convert his entire note into common stock, for a total 1,000,000 common shares, to be issued within 10 days.
The principal amount of the Note is not material to Amarantus and if converted, the number of shares issued in conversion would be less that one percent (1%) of the outstanding shares of Amarantus.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8886767
>>MAKING MILLIONS!!!!<< Join Today!
http://investorshub.advfn.com/boards/board.aspx?board_id=15619
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM